News
MIMETAS in the global news. Read more about our latest research, developments, collaborations, and product launches.
Sign up for our newsletter to stay up to date.
MIMETAS to Participate in Holomicrobiome Institute, Backed by €200 Million from Dutch Cabinet
MIMETAS Participates in €124.5 million Initiative to Transition to Animal-free Innovation
Innovative Gut-on-a-Chip Platform Paves the Way for Enterotoxin Research Breakthroughs
MIMETAS participates in GRIPonMASH initiative to improve prevention and care of Metabolic dysfunction-Associated Steatohepatitis (MASH)
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development
Microfluidic Models of the Neurovascular Unit: A Translational View
MIMETAS Co-CEO, Paul Vulto, nominated as new Netherlands Academy of Engineering Fellow
Human BBB-on-a-chip Reveals Barrier Disruption, Endothelial Inflammation, and T-Cell Migration Under Neuroinflammatory Conditions
The First Large-Scale Phenotypic Screen Using Organ-on-a-Chip: A 1537 Kinase Inhibitor Library Screen on a 3D Angiogenesis Assay
MIMETAS and Dundee Placenta Model Could Transform Pregnancy Healthcare
The National Growth Fund Reserves 125 million euros for the Transition to Animal-Free Innovation
MIMETAS and Astellas Expand Partnership to Include Automation and Application Support
No items found...